Grant: Engage Grants Program
McGill University
$25,000.00
Feasibility evaluation of engineered albucore nanoparticles for drug encapsulation.
FY 2014-15
Summary
Based on albumin sequence, structure and information derived from computational modeling and simulation,Zymeworks Inc. has devised a proprietary method to determine locations in the albumin sequence wherein asplice can be engineered in the backbone such that it yields two protein chain components we refer to asAlbuCORETM. The goal this engage grant is to evaluate the feasibility of producing an engineered albuminbased receptor targeting nanoparticle as drug delivery platform for Zymeworks Inc. Achieving targeted andcontrolled release of the drug requires exquisite molecular engineering of the material used to prepare thesenanoparticles. This study would assist Zymeworks Inc in its plan to develop a novel drug delivery system usingthis biocompatible protein material that can target diseased cells and release therapeutics in a controlledmanner. The proposal will provide data for long term studies and foster industrial and Universitycollaborations.
Program
Engage Grants Program
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
474295-2014
Name nom
Prakash, Satya
Department département
Biomedical Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
508
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Polymers, rubber and plastics
Area of application fr
Polymères, caoutchouc et plastiques
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
1
Nb partie
1
Application title
Feasibility evaluation of engineered albucore nanoparticles for drug encapsulation.
Keyword
NSERC
Application summary
Based on albumin sequence, structure and information derived from computational modeling and simulation,Zymeworks Inc. has devised a proprietary method to determine locations in the albumin sequence wherein asplice can be engineered in the backbone such that it yields two protein chain components we refer to asAlbuCORETM. The goal this engage grant is to evaluate the feasibility of producing an engineered albuminbased receptor targeting nanoparticle as drug delivery platform for Zymeworks Inc. Achieving targeted andcontrolled release of the drug requires exquisite molecular engineering of the material used to prepare thesenanoparticles. This study would assist Zymeworks Inc in its plan to develop a novel drug delivery system usingthis biocompatible protein material that can target diseased cells and release therapeutics in a controlledmanner. The proposal will provide data for long term studies and foster industrial and Universitycollaborations.